XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance, beginning (in shares) at Dec. 31, 2020   16,896,626      
Balance, beginning at Dec. 31, 2020 $ 62,030 $ 17 $ 91,278 $ 122 $ (29,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 162   162    
Net income (loss) 175       175
Other comprehensive income (loss), net of tax (202)     (202)  
Balance, ending (in shares) at Mar. 31, 2021   16,896,626      
Balance, ending at Mar. 31, 2021 62,165 $ 17 91,440 (80) (29,212)
Balance, beginning (in shares) at Dec. 31, 2020   16,896,626      
Balance, beginning at Dec. 31, 2020 62,030 $ 17 91,278 122 (29,387)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (829)        
Other comprehensive income (loss), net of tax 200        
Balance, ending (in shares) at Jun. 30, 2021   17,497,910      
Balance, ending at Jun. 30, 2021 65,480 $ 18 95,356 322 (30,216)
Balance, beginning (in shares) at Mar. 31, 2021   16,896,626      
Balance, beginning at Mar. 31, 2021 62,165 $ 17 91,440 (80) (29,212)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued from vesting of stock-based awards (in shares)   101,284      
Stock-based compensation 122   122    
Shares issued in asset acquisition (in shares)   500,000      
Shares issued in asset acquisition 3,795 $ 1 3,794    
Net income (loss) (1,004)       (1,004)
Other comprehensive income (loss), net of tax 402     402  
Balance, ending (in shares) at Jun. 30, 2021   17,497,910      
Balance, ending at Jun. 30, 2021 65,480 $ 18 95,356 322 (30,216)
Balance, beginning (in shares) at Dec. 31, 2021   17,691,268      
Balance, beginning at Dec. 31, 2021 61,059 $ 18 97,875 351 (37,185)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued from vesting of stock-based awards (in shares)   501,334      
Stock-based compensation 531   531    
Net income (loss) (406)       (406)
Other comprehensive income (loss), net of tax 377     377  
Balance, ending (in shares) at Mar. 31, 2022   18,192,602      
Balance, ending at Mar. 31, 2022 61,561 $ 18 98,406 728 (37,591)
Balance, beginning (in shares) at Dec. 31, 2021   17,691,268      
Balance, beginning at Dec. 31, 2021 $ 61,059 $ 18 97,875 351 (37,185)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Shares issued in asset acquisition (in shares) 500,000        
Net income (loss) $ (2,574)        
Other comprehensive income (loss), net of tax (575)        
Balance, ending (in shares) at Jun. 30, 2022   18,279,939      
Balance, ending at Jun. 30, 2022 59,049 $ 18 99,014 (224) (39,759)
Balance, beginning (in shares) at Mar. 31, 2022   18,192,602      
Balance, beginning at Mar. 31, 2022 61,561 $ 18 98,406 728 (37,591)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued from vesting of stock-based awards (in shares)   87,337      
Stock-based compensation 608   608    
Net income (loss) (2,168)       (2,168)
Other comprehensive income (loss), net of tax (952)     (952)  
Balance, ending (in shares) at Jun. 30, 2022   18,279,939      
Balance, ending at Jun. 30, 2022 $ 59,049 $ 18 $ 99,014 $ (224) $ (39,759)